Eli Lilly to Boost Obesity Drug Supply With Germany Factory
April 10, 2024
6,153
122
4
2.05%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg News Episodes Around April 10, 2024
See what was published immediately before and after this episode.
0:55Now PlayingEli Lilly to Boost Obesity Drug Supply With Germany Factory
YouTube Description
as posted by the channelEli Lilly & Co. kicked off construction of a plant to boost the production of its wildly popular weight-loss drugs, which have yet to gain a foothold in Europe.
The factory will open in 2027 and ship worldwide, the US drugmaker said at the groundbreaking ceremony near Frankfurt on Monday.
Lilly is starting work on the plant as its weight-loss blockbuster Zepbound faces shortages in the US and the company races against Novo Nordisk A/S to supply the world with a new generation of injected obesity medicines.
--------
Subscribe to our YouTube channel
Subscribe to Bloomberg Originals
Bloomberg Quicktake brings you global social video spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
Connect with us on…
Breaking News on YouTube
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.